Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+8.57M
-
Total reported value, excl. options
-
$54.7M
-
Value change
-
+$27.5M
-
Number of buys
-
19
-
Number of sells
-
-6
-
Price
-
$3.21
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2017
27 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2017.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 237M outstanding shares and own 7.19% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.82M shares), Aisling Capital LLC (3.61M shares), Consonance Capital Management LP (3.37M shares), Biomark Capital Management Co. LLC (1.43M shares), Broadfin Capital, LLC (1.1M shares), 683 Capital Management, LLC (950K shares), Vanguard Group Inc (640K shares), Iguana Healthcare Management, LLC (600K shares), MORGENS WATERFALL VINTIADIS & CO INC (500K shares), and HIGHBRIDGE CAPITAL MANAGEMENT LLC (313K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.